TG
DPLO

TCW Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

TCW Group’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-117,585
Closed -$1.48M – 656
2016
Q4 		$1.48M Buy
117,585
+77,744
+195% +$1.45M 0.01% 416
2016
Q3 		$1.12M Sell
39,841
-2,745
-6% -$92.1K 0.01% 450
2016
Q2 		$1.49M Sell
42,586
-64,257
-60% -$2.02M 0.01% 397
2016
Q1 		$2.93M Sell
106,843
-101,986
-49% -$3M 0.02% 262
2015
Q4 		$7.15M Buy
208,829
+72,637
+53% +$2.27M 0.05% 158
2015
Q3 		$3.91M Sell
136,192
-185,830
-58% -$7.95M 0.03% 215
2015
Q2 		$14.4M Buy
322,022
+79,695
+33% +$3M 0.09% 139
2015
Q1 		$8.38M Buy
+242,327
New +$6.59M 0.04% 288

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TCW Group's DPLO Position: Q1 2017 in Review

TCW Group sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2017, closing a stake of 117,585 shares — an estimated $1.48M sold.

TCW Group first reported a position in DPLO in Q1 2015 and held it in 8 quarters. The position peaked at $14.4M in Q2 2015. 155 funds tracked by Wall St. Rank hold DPLO as of Q1 2017.

  • TCW Group reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2017 after selling out during the quarter.
  • TCW Group sold 117,585 DIPLOMAT PHARMACY, INC. shares in Q1 2017, an estimated $1.48M.
  • TCW Group first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2015 and held it in 8 quarters.
  • TCW Group's DIPLOMAT PHARMACY, INC. position peaked at $14.4M in Q2 2015.
  • 155 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2017.

Based on TCW Group's 13F filing for Q1 2017, filed 12 May 2017.